Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.46 |
| ▸ | ESRRA | P11474 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CCR1 | P32246 | 1/20 | 0.36 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
| ▸ | CCR8 | P51685 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13320308 | 0.85 | CYP11B1 (0.59) | CYP11B1GPR84NPC1KMT2AMEN1 | |
| SCHEMBL4401757 | 0.84 | CCR1 (0.50) | ESRRANPC1ABL1KMT2ACYP3A4 | |
| SCHEMBL4402808 | 0.81 | DHODH (0.43) | ESRRANPC1ABL1KMT2ACYP3A4 | |
| SCHEMBL13320296 | 0.81 | CYP11B1 (0.57) | CYP11B1GPR84NPC1KMT2AMEN1 | |
| SCHEMBL4402811 | 0.80 | TGFBR1 (0.44) | ESRRANPC1KMT2ACYP1A2CYP2C9 | |
| SCHEMBL13776866 | 0.79 | MEN1 (0.48) | CYP11B1GPR84ADORA3KMT2ARECQL | |
| SCHEMBL4402496 | 0.79 | DHODH (0.42) | ESRRANPC1ABL1KMT2ACYP3A4 | |
| SCHEMBL24910257 | 0.75 | CYP11B1 (0.50) | CYP11B1GPR84NPC1KMT2AMEN1 | |
| SCHEMBL29832045 | 0.75 | CYP11B1 (0.50) | CYP11B1GPR84NPC1KMT2AMEN1 | |
| SCHEMBL22918006 | 0.74 | CYP11B1 (0.43) | CYP11B1GPR84NPC1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168307-B2 | Organic compound, charge transport material and organic electroluminescent device | PIONEER CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | PIONEER CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC25A21, SLCO2A1, OCIAD2 | CYP11B1 503/4885ESRRA 3444/4885GPR84 3870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.